|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Recent evolution of antibiotic resistance in the anaerobes as compared to previous decades显示文摘 | Boyanova L Kolarov R Mitov I | 2015 | Anaerobe2015，31，1： | 1 |
| 2 | High prevalence of virulent Helicobacter pylori strains in symptomatic Bulgarian patients 显示文摘 | Boyanova L Markovska R Yordanov D | 2009 | Diagn Microbiol Infect Dis2009，64，4： | 1 |
| 3 | The status of antimicrobial resistance of helicobacter pyroli in eastern Europe 显示文摘 | BOYANOVA L MENTIS A GUBINA M | 2002 | Clin Microbiol Infect2002，8，7： | 1 |
| 4 | Geographic map and evolution of primary Helicobaeter pylofi resistance to antibacterial agents显示文摘 | Boyanova L Mitov I | 2010 | Expert Rev Anti Infect Ther2010，8，： | 1 |
| 5 | Trends in antibiotic resistance in Prevotella species from patients of the University Hospital of Maxillofacial Surgery, Sofia, Bulgaria, in 2003-2009 显示文摘 | BOYANOVA L KOLAROV R GERGOVA G | 2010 | Anaerobe2010，16，5： | 1 |
| 6 | Prevalence of multidrug-resistant Helicobacter pylori in Bulgaria 显示文摘 | Boyanova L | 2009 | J of Med Microbiol2009，58，7： | 1 |
| 7 | Geographic map and evolution of primary Helico- bacter pylori resistance to antibacterial agents 显示文摘 | Boyanova L Mitov I | 2010 | Expert Rev Anti In- fect Ther2010，8，1： | 1 |
| 8 | Ombitasvir, paritaprevir, ritonavir, dasabuvir and ribavirin in cirrhosis after complete destruction of hepatocellular carcinoma显示文摘We observed a sustained viral response(SVR) of ombitasvir/paritaprevir/ritonavir, dasabuvir and ribavirin therapy, for 12 wk, in two cases with compensated liver cirrhosis and fully destroyed early hepatocellular carcinoma(HCC). Patients were infected with hepatitis C virus(HCV) genotype 1b and were previous null responders/relapsers to interferon-alpha/ribavirin(IFN/RBV). There was a rapid suppression of HCV RNA to undetectable levels within the first two treatment weeks. SVR was achieved even after marked reduction of the RBV dose. The treatment was well tolerated. Both subjects experienced worsening of liver disease during therapy, in different patterns: severe, transient, predominantly direct hyperbilirubinemia without cytolysis(case 1) or progressive increase of aminotransferases(grade 4) without severe hyperbilirubinemia(case 2).Adverse events spontaneously resolved. The patients remained in a good clinical condition without hepatic decompensation. There was no re-occurrence of HCC. This is the first report for treatment of HCV cirrhosis after complete HCC destruction. | Zahariy Krastev Deian Jelev Krasimir Antonov Tanya Petkova Evelina Atanasova Nadezhda Zheleva Bojidar Tomov Yana Boyanova Lyudmila Mateva | 2016 | World Journal of Gastroenterology2016，22，8： | 1 |
| 9 | Antibacterial resistance in Helicobacter pylori strains isolated from Bulgarian children and adult patients over 9 years 显示文摘 | Boyanova L Nikolov R Lazarova E | 2006 | J Med Microbiol2006，55，65： | 1 |
| 10 | Risk factors for primary Helicobacter pylori resistance in Bulgarian children 显示文摘 | Boyanova L Gergova G Koumanova R | 2004 | J Med Microbiol2004，53，9： | 1 |
| 11 | Characterization of oral Helicobacter pylori strain by four methods显示文摘 | Lyudmila Boyanova Vladimir Panov Daniel Yordanov Galina Gergova Ivan Mitov | 2013 | Diagnostic Microbiology & Infectious Disease2013，，： | 1 |
| 12 | Primary and combined resistance to four antimicrobial agents in Helicobacter pylori in Sofia, Bugaria显示文摘 | Boyanova L Stancheva I Spassova Z | 2000 | J Med Microbiot2000，49，5： | 1 |
| 13 | Prevalence and evolution of Helicobacter pylori resistance to 6 antibacterial agents over 12 years and correlation between susceptibility testing methods显示文摘 | Boyanova L Gergova G Nikolov R | 2008 | Diagn Micro- biol Infect Dis2008，60，4： | 1 |
| 14 | The status of antimicrobial resistance of Helicobacter pyroli in eastern Europe 显示文摘 | BOYANOVA L MENTIS A GUBINA M | 2002 | Clin Microbiol Infect2002，8，7： | 1 |
| 15 | Evaluation of Helicobacter pylori eradication by triple therapy plus Lactobacillus acidophilus compared to triple therapy alone显示文摘 | Medeiros JA Goncalves TM Boyanova L | 2011 | Eur J Clin Microbiol Infect Dis2011，30，4： | 1 |
| 16 | Prevalence andevolution of Helicobacter pylori resistance to 6 antibacterialagents over 12 years and correlation between susceptibilitytesting methods显示文摘 | Boyanova L Gergova G Nikolov R | 2008 | Diagn Microbiol Infect Dis2008，60，4： | 1 |
| 17 | Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents显示文摘 | Boyanova L Mitov I | | 0，，： | 1 |
| 18 | Helicobacter pylori oipA genetic diversity and its associations with both disease and cagA,vacA s,m,and i alleles among Bulgarian patients显示文摘 | Markovska R Boyanova L Yordanov D | | 0，，： | 1 |
| 19 | Anti - Helicobacter pylori activity of Lactobacillus delbrueckii subsp bulgaricus strains: preliminary report 显示文摘 | Boyanova L Stephanova - Kondratenko M Mitov I | 2009 | Letters in Applied Microbiology2009，48，： | 1 |
| 20 | The status of antimicrobial resistance of Helicobacter pylori in Eastern Europe显示文摘 | Boyanova L Mentis A Gubina M | 2002 | Clin Microbiol Infect2002，8，7： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员